In the original publication, the names of the BRIVAFIRST group members were incorrectly presented and tagged in the Acknowledgements section. This has now been corrected as follows.

Lattanzi S., Canafoglia L., Canevini M.P., Casciato S., Chiesa V., Dainese F., et al. (2021). Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST). CNS DRUGS, 35(12), 1329-1331 [10.1007/s40263-021-00868-z].

Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST)

Gangitano M.;
2021-12-01

Abstract

In the original publication, the names of the BRIVAFIRST group members were incorrectly presented and tagged in the Acknowledgements section. This has now been corrected as follows.
dic-2021
Lattanzi S., Canafoglia L., Canevini M.P., Casciato S., Chiesa V., Dainese F., et al. (2021). Correction to: Adjunctive Brivaracetam in Focal Epilepsy: Real‑World Evidence from the BRIVAracetam add‑on First Italian netwoRk Study (BRIVAFIRST). CNS DRUGS, 35(12), 1329-1331 [10.1007/s40263-021-00868-z].
File in questo prodotto:
File Dimensione Formato  
40263_2021_Article_868.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 468.94 kB
Formato Adobe PDF
468.94 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/555674
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 4
social impact